Linklaters advises QIAGEN N.V. on the agreement with EQT Private Equity on an all-cash public takeover offer for all outstanding QIAGEN shares, at an offer price of €46.50 per share. The bidder is a holding company indirectly controlled by EQT XI fund with further indirect participations held by co-investors Luxinva S.A., a wholly-owned subsidiary of the Abu Dhabi Investment Authority, and CPP Investment Board Europe Inc., a wholly-owned subsidiary of Canada Pension Plan Investment Board.
The transaction values QIAGEN at approx. €10.8bn in enterprise value – approx. $12.1bn at current exchange rates, including approximately $1.1bn of net debt.
QIAGEN N.V., a Netherlands-based holding company, is a global leader in Sample to Insight solutions that enable customers to extract and analyse molecular information from biological samples containing the building blocks of life. QIAGEN serves more than 500,000 customers worldwide in the Life Sciences and clinical healthcare sectors. It employs about 5,400 people across more than 35 locations.
An international cross-practice Linklaters team led by Corporate/M&A partner Staffan Illert and Daniela Seeliger (Antitrust & Foreign Investment) advised QIAGEN on this complex landmark transaction. The team also included partner David dos Santos Goncalves (Antitrust & Foreign Investment), Alexander Schlee (Capital Markets), counsels Ben Bauer (Antitrust & Foreign Investment, New York), Ulli Janssen (Corporate/M&A), Tobias Rump (Antitrust & Foreign Investment), Will Creswell (Capital Markets), Urs Lewens (Banking), managing associates Kevin Eisenschmidt (Corporate/M&A), Catrin Retzmann (Capital Markets) and associates Kathy Choi (London) and Theresa Noßke (both Antitrust & Foreign Investment).
Linklaters is a leading advisor on complex cross-border M&A transactions. In the latest M&A rankings of LSEG, the firm was listed No.1 for completed deals with German involvement, having advised on 31 deals with a total value of about $38bn, reflecting a market share of 28% (1/1/26-30/09/26).
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
